Annette Clancy
Chairman bij SWEDISH ORPHAN BIOVITRUM AB
Vermogen: 90 719 $ op 31-03-2024
Actieve functies van Annette Clancy
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
SWEDISH ORPHAN BIOVITRUM AB | Independent Dir/Board Member | 08-05-2014 | - |
Chairman | 05-01-2024 | - | |
Director/Board Member | 08-05-2014 | 05-01-2024 | |
Abcd Ltd. | Director/Board Member | - | - |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Chairman | - | - |
Independent Dir/Board Member | - | - |
Loopbaan van Annette Clancy
Eerdere bekende functies van Annette Clancy
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OBSEVA SA | Director/Board Member | 01-12-2016 | 18-05-2022 |
Chairman | 18-05-2022 | 10-03-2023 | |
Independent Dir/Board Member | 01-11-2013 | 10-03-2023 | |
LYSOGENE | Director/Board Member | 22-05-2019 | 26-09-2019 |
Chairman | 14-04-2015 | 22-05-2019 | |
Independent Dir/Board Member | 22-05-2019 | 26-09-2019 | |
WEIFA ASA | Director/Board Member | 20-05-2010 | 21-05-2013 |
SILENCE THERAPEUTICS PLC | Director/Board Member | 01-07-2008 | 02-08-2012 |
GSK PLC | Corporate Officer/Principal | 01-01-1978 | 01-01-2008 |
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Chairman | - | - |
Opleiding van Annette Clancy
University of Bath | Undergraduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 5 |
Frankrijk | 3 |
Noorwegen | 2 |
Operationeel
Director/Board Member | 6 |
Chairman | 5 |
Independent Dir/Board Member | 4 |
Sectoraal
Health Technology | 7 |
Commercial Services | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
GSK PLC | Health Technology |
SILENCE THERAPEUTICS PLC | Commercial Services |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
OBSEVA SA | Health Technology |
LYSOGENE | Commercial Services |
Bedrijven in privébezit | 4 |
---|---|
Weifa ASA
Weifa ASA Pharmaceuticals: MajorHealth Technology Weifa ASA engages in the development, production and sales of medicines and other health products. Its products include medicines for pain relief, cough and cold, nutraceuticals, and dermatology. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Health Technology |
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Health Technology |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Health Technology |
Abcd Ltd. |
- Beurs
- Insiders
- Annette Clancy
- Ervaring